Figure 5. GSEA enrichment between high- and low-risk groups. GSEA enrichment based on (A) the 3CA metaprograms and the cell type signature gene sets, (B) the canonical pathways gene sets derived from the KEGG, Reactome and WikiPathways pathway database, (C) the oncogenic signature gene sets and (D) the transcription factor targets (TFT) gene sets.